Hanmi Pharmaceutical

Update in progress

008930.KS (KSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Distribution

Hanmi Science Co., Ltd. develops, manufactures, and sells pharmaceutical products in Korea and abroad. It focuses on diabetes and cancer drugs, bowel preparation and cold medicines for children and adults, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment, plus automated drug management systems. Products are sold through online and offline pharmacies. Founded in 1973 and headquartered in Seoul, it was renamed in 2012 from Hanmi Holdings.

Company score

Sentiment: 0.43; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.32; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.20; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.14; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.28; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive